AI-generated summary
The authors studied abdominal photobiomodulation at 630, 730 and 850 nm in an amyloid-beta-induced Alzheimer's model in mice over eight weeks. They report improved performance on a water maze test, reduced amyloid and tau markers in the hippocampus, and altered gut bacteria composition. This is an animal study, so the findings may not apply to people.
- Who or what was studied
- Amyloid-beta-induced Alzheimer's disease mouse model
- Wavelengths
- 630, 730, 850 nm
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not report the number of animals.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm, 730 nm, 850 nm
- Energy density (fluence)
- 100 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Dementia, Wound healing, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.